Listed cancer diagnostics company Pacific Edge will likely need to raise more capital in the next 12 months, analysts at Forsyth Barr say.
Pacific Edge yesterday reported a net loss after tax of $14.5 million for the six months ended September 30, a 5% improvement on the previous corresponding
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
